BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36035363)

  • 1. Conversion of hepatitis B virus relaxed circular to covalently closed circular DNA is supported in murine cells.
    Wei L; Cafiero TR; Tseng A; Gertje HP; Berneshawi A; Crossland NA; Ploss A
    JHEP Rep; 2022 Sep; 4(9):100534. PubMed ID: 36035363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Analysis of Nuclear Hepatitis B Virus Relaxed Circular DNA-Associated Proteins Identifies UV-Damaged DNA Binding Protein as a Host Factor Involved in Covalently Closed Circular DNA Formation.
    Marchetti AL; Zhang H; Kim ES; Yu X; Jang S; Wang M; Guo H
    J Virol; 2022 Jan; 96(2):e0136021. PubMed ID: 34705558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited disassembly of cytoplasmic hepatitis B virus nucleocapsids restricts viral infection in murine hepatic cells.
    Zhao K; Guo F; Wang J; Zhong Y; Yi J; Teng Y; Xu Z; Zhao L; Li A; Wang Z; Chen X; Cheng X; Xia Y
    Hepatology; 2023 Apr; 77(4):1366-1381. PubMed ID: 35718932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus cccDNA is formed through distinct repair processes of each strand.
    Wei L; Ploss A
    Nat Commun; 2021 Mar; 12(1):1591. PubMed ID: 33707452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMO Modification of Hepatitis B Virus Core Mediates Nuclear Entry, Promyelocytic Leukemia Nuclear Body Association, and Efficient Formation of Covalently Closed Circular DNA.
    Hofmann S; Plank V; Groitl P; Skvorc N; Hofmann K; Luther J; Ko C; Zimmerman P; Bruss V; Stadler D; Carpentier A; Rezk S; Nassal M; Protzer U; Schreiner S
    Microbiol Spectr; 2023 Jun; 11(3):e0044623. PubMed ID: 37199632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Termini of Cytoplasmic Hepatitis B Virus Deproteinated Relaxed Circular DNA.
    Cai D; Yan R; Xu JZ; Zhang H; Shen S; Mitra B; Marchetti A; Kim ES; Guo H
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33055252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA.
    Sheraz M; Cheng J; Tang L; Chang J; Guo JT
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus.
    Kitamura K; Que L; Shimadu M; Koura M; Ishihara Y; Wakae K; Nakamura T; Watashi K; Wakita T; Muramatsu M
    PLoS Pathog; 2018 Jun; 14(6):e1007124. PubMed ID: 29928064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
    Qi Y; Gao Z; Xu G; Peng B; Liu C; Yan H; Yao Q; Sun G; Liu Y; Tang D; Song Z; He W; Sun Y; Guo JT; Li W
    PLoS Pathog; 2016 Oct; 12(10):e1005893. PubMed ID: 27783675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Repair Factor Poly(ADP-Ribose) Polymerase 1 Is a Proviral Factor in Hepatitis B Virus Covalently Closed Circular DNA Formation.
    Chen Y; Yao Y; Zhao K; Liu C; Yuan Y; Sun H; Huang D; Zheng Y; Zhou Y; Chen J; Wang Y; Wu C; Zhang B; Guan Y; Li F; Pei R; Chen X
    J Virol; 2022 Jul; 96(13):e0058522. PubMed ID: 35862693
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Tu T; Zehnder B; Qu B; Urban S
    JHEP Rep; 2021 Feb; 3(1):100195. PubMed ID: 33385130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.
    Guo H; Jiang D; Zhou T; Cuconati A; Block TM; Guo JT
    J Virol; 2007 Nov; 81(22):12472-84. PubMed ID: 17804499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B Virus Capsid: The Core in Productive Entry and Covalently Closed Circular DNA Formation.
    Mendenhall MA; Hong X; Hu J
    Viruses; 2023 Feb; 15(3):. PubMed ID: 36992351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels.
    Ko C; Chakraborty A; Chou WM; Hasreiter J; Wettengel JM; Stadler D; Bester R; Asen T; Zhang K; Wisskirchen K; McKeating JA; Ryu WS; Protzer U
    J Hepatol; 2018 Dec; 69(6):1231-1241. PubMed ID: 30142426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T5 Exonuclease Hydrolysis of Hepatitis B Virus Replicative Intermediates Allows Reliable Quantification and Fast Drug Efficacy Testing of Covalently Closed Circular DNA by PCR.
    Qu B; Ni Y; Lempp FA; Vondran FWR; Urban S
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation.
    Wei L; Ploss A
    Nat Microbiol; 2020 May; 5(5):715-726. PubMed ID: 32152586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel vector preS1-tp fusion protein effectively inhibits hepatitis B virus replication and cccDNA synthesis by mediating hepatitis B virus targeting sequence small interfering RNA].
    Zeng YL; Gao F; Zhang C; Wei JF; Ma L; Ding GG; Li W; Shang J; Kang Y
    Zhonghua Gan Zang Bing Za Zhi; 2021 Feb; 29(2):126-132. PubMed ID: 33685080
    [No Abstract]   [Full Text] [Related]  

  • 18. Heat Shock Protein Family A Member 1 Promotes Intracellular Amplification of Hepatitis B Virus Covalently Closed Circular DNA.
    Tang L; An P; Zhao Q; Winkler CA; Chang J; Guo JT
    J Virol; 2023 Jan; 97(1):e0126122. PubMed ID: 36519896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untying relaxed circular DNA of hepatitis B virus by polymerase reaction provides a new option for accurate quantification and visualization of covalently closed circular DNA.
    Kamiya N; Sugimoto T; Abe-Chayama H; Akiyama R; Tsuboi Y; Mogami A; Imamura M; Hayes CN; Chayama K
    J Gen Virol; 2022 Feb; 103(2):. PubMed ID: 35130138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.
    Cai D; Mills C; Yu W; Yan R; Aldrich CE; Saputelli JR; Mason WS; Xu X; Guo JT; Block TM; Cuconati A; Guo H
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4277-88. PubMed ID: 22644022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.